The efficacy of unrelated cord blood transplantation for adult myelodysplastic syndrome

References

• Anderson J E, Anasetti E, Appelbaum F R, Schoch G, Gooley T A, Hansen J A, et al. Unrelated donor transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukemia. Br J Haematol 1996; 93: 59–67
   PubMed Web of Science ®Google Scholar
• Arnold R, De Witte T, Van Biezen A, Hermans J, Jacobsen N, Runde V, et al. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. Bone Marrow Transplant 1998; 21: 1213–1216
   PubMed Web of Science ®Google Scholar
• De Witte T, Hermans J, Vossen J, Bacigalupo A, Meloni G, Jacobsen N, et al. Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2000; 110: 620–630
   PubMed Web of Science ®Google Scholar
• De Witte T, Pikkemaat F, Hermans J, van Biezen A, Mackinnan S, Cornelissen J, et al. Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation. Leukemia 2001; 15: 1878–1884
   PubMed Web of Science ®Google Scholar
• Deeg H J, Storer B, Slattery J T, Anasetti C, Doney K C, Hansen J A, et al. Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood 2002; 100: 1201–1207
   PubMed Web of Science ®Google Scholar
• Ooi J, Iseki T, Takahashi S, Tomonari A, Ishii K, Takasugi K, et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 2003; 101: 4711–4713
   PubMed Web of Science ®Google Scholar
• Ooi J, Iseki T, Takahashi S, Tomonari A, Takasugi K, Uchiyama M, et al. Unrelated cord blood transplantation after myeloablative conditioning for adult patients with refractory anemia. Int J Hematol 2005; 81: 424–427
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Glucksberg H, Storb R, Fefer A, Buckner C D, Neiman P E, Clift R A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, Klingemann H G, Beatty P, Hows J, et al. 1994. Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825–828
   PubMed Web of Science ®Google Scholar
• Shulman H M, Sullivan K M, Weiden P L, McDonald G B, Striker G E, Sale G E, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217
   PubMed Web of Science ®Google Scholar
• Anderson J E, Gooley T A, Schoch G, Anasetti C, Bensinger W I, Clift R A, et al. Stem cell transplantation for secondary acute myeloid leukemia. Evaluation of transplantation as initial therapy or following induction chemotherapy. Blood 1997; 89: 578–585
   Google Scholar
• Takahashi S, Okamoto S I, Shirafuji N, Ikebuchi K, Tani K, Shimane M, et al. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. Bone Marrow Transplant 1994; 13: 239–245
   PubMed Web of Science ®Google Scholar
• Okamoto S, Takahashi S, Wakui M, Ishida A, Tanosaki R, Ikeda Y, et al. Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony-stimulating factor preceding allogeneic bone marrow transplantation. Br J Haematol 1997; 104: 569–573
   Web of Science ®Google Scholar
• Ooi J, Iseki T, Takahashi S, Tomonari A, Takasugi K, Shimohakamada M, et al. Unrelated cord blood transplantation after myeloablative conditioning in patients over the age of 45 years. Br J Haematol 2004; 126: 711–714
   PubMed Web of Science ®Google Scholar
• Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Uchiyama M, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004; 104: 3813–3820
   PubMed Web of Science ®Google Scholar
• Laughlin M J, Barker J, Bambach B, Koc O N, Rizzieri D A, Wagner J E, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822
   PubMed Web of Science ®Google Scholar
• Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000; 28: 1197–1205
   PubMed Web of Science ®Google Scholar
• Sanz G F, Saavedra S, Planelles D, Senent L, Cervera J, Barragan E, et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001; 98: 2332–2338
   PubMed Web of Science ®Google Scholar
• Long G D, Laughlin M, Madan B, Kurtzberg J, Gasparetto C, Morris A, et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003; 9: 772–780
   PubMed Web of Science ®Google Scholar
• Laughlin M J, Eapen M, Rubinstein P, Wagner J E, Zhang M J, Champlin R E, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265–2275
   PubMed Web of Science ®Google Scholar